Australian Clinical Labs Ltd
ASX:ACL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd
Cash & Cash Equivalents
Australian Clinical Labs Ltd
Cash & Cash Equivalents Peer Comparison
HLA
SHL
IDX
CAJ
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Cash & Cash Equivalents
AU$20m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Healthia Ltd
ASX:HLA
|
Cash & Cash Equivalents
AU$5.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Cash & Cash Equivalents
AU$619.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Cash & Cash Equivalents
AU$18m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Cash & Cash Equivalents
AU$19.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
28%
|
CAGR 10-Years
13%
|
|
H
|
Healius Ltd
ASX:HLS
|
Cash & Cash Equivalents
AU$85.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
24%
|
See Also
What is Australian Clinical Labs Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
20m
AUD
Based on the financial report for Jun 30, 2023, Australian Clinical Labs Ltd's Cash & Cash Equivalents amounts to 20m AUD.
What is Australian Clinical Labs Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
24%
Over the last year, the Cash & Cash Equivalents growth was -24%. The average annual Cash & Cash Equivalents growth rates for Australian Clinical Labs Ltd have been -17% over the past three years , 24% over the past five years .
You don't have any saved screeners yet
